Witnessing the stock’s movement on the chart, on Wednesday, Harvard Bioscience Inc (NASDAQ: HBIO) set off with pace as it heaved 11.65% to $0.45, before settling in for the price of $0.4 at the close. Taking a more long-term approach, HBIO posted a 52-week range of $0.28-$2.82.
In the past 5-years timespan, the Healthcare sector firm’s annual sales growth was -18.10%. Meanwhile, its Annual Earning per share during the time was -18.10%. Nevertheless, stock’s Earnings Per Share (EPS) this year is -16.67%. This publicly-traded company’s shares outstanding now amounts to $44.53 million, simultaneously with a float of $38.07 million. The organization now has a market capitalization sitting at $19.88 million. At the time of writing, stock’s 50-day Moving Average stood at $0.4502, while the 200-day Moving Average is $0.6370.
Harvard Bioscience Inc (HBIO) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Medical Instruments & Supplies industry. Harvard Bioscience Inc’s current insider ownership accounts for 14.50%, in contrast to 43.87% institutional ownership.
Harvard Bioscience Inc (HBIO) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.04 per share during the current fiscal year.
Harvard Bioscience Inc’s EPS decrease for this current 12-month fiscal period is -16.67% and is forecasted to reach 0.12 in the upcoming year.
Harvard Bioscience Inc (NASDAQ: HBIO) Trading Performance Indicators
Let’s observe the current performance indicators for Harvard Bioscience Inc (HBIO). It’s Quick Ratio in the last reported quarter now stands at 0.41. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 0.22. Similarly, its price to free cash flow for trailing twelve months is now 4.51.
In the same vein, HBIO’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.30, a figure that is expected to reach 0.01 in the next quarter, and analysts are predicting that it will be 0.12 at the market close of one year from today.
Technical Analysis of Harvard Bioscience Inc (HBIO)
Going through the that latest performance of [Harvard Bioscience Inc, HBIO]. Its last 5-days volume of 0.83 million was inferior to the volume of 4.05 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 59.42% While, its Average True Range was 63.72.
Raw Stochastic average of Harvard Bioscience Inc (HBIO) in the period of the previous 100 days is set at 26.06%, which indicates a major fall in contrast to 88.97% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.0257 that was lower than 0.0395 volatility it exhibited in the past 100-days period.
